Splash Beverage Group reported a loss from continuing operations of approximately $4 million for the first half of 2026, a 64% improvement from the $11 million loss in the prior year period, driven by cost-reduction initiatives. The company is transitioning its business focus to cannabinoid health and wellness products under the new name Endovia Health Sciences, with a ticker change expected on August 24, 2026. Post-quarter strategic moves include an exclusive global license for CannEpil®, a veterinary expansion of that license via a collaboration with Lupvindol Biosciences, and preparations to relaunch CannEpil in international markets. Splash Beverage Group operates in the beverage and health sciences industry.
